Drug repurposing and cytokine management in response to COVID-19: A review
- 1 November 2020
- journal article
- review article
- Published by Elsevier in International Immunopharmacology
- Vol. 88, 106947
Abstract
No abstract availableKeywords
Funding Information
- Universiteit van die Vrystaat
- Fundação de Apoio à Pesquisa e à Inovação Tecnológica do Estado de Sergipe
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Universidade Federal de Sergipe
This publication has 157 references indexed in Scilit:
- Anti-inflammatory effect of thalidomide in paraquat-induced pulmonary injury in miceInternational Immunopharmacology, 2013
- Inhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirinScientific Reports, 2013
- LPS-Stimulated Cytokine Production in Type I Cells Is Modulated by the Renin–Angiotensin SystemAmerican Journal of Respiratory Cell and Molecular Biology, 2012
- Changing Perceptions: of Pandemic Influenza and Public Health ResponsesAmerican Journal of Public Health, 2012
- Overview of the biology of type I interferonsArthritis Research & Therapy, 2010
- IL‐1β receptor blockade protects islets against pro‐inflammatory cytokine induced necrosis and apoptosisJournal of Cellular Physiology, 2009
- The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptorNature, 2008
- The Pharmacokinetics and Interactions of Ivermectin in Humans—A Mini-reviewThe AAPS Journal, 2008
- Historical insights into cytokinesEuropean Journal of Immunology, 2007
- Differing effects of clarithromycin and azithromycin on cytokine production by murine dendritic cellsClinical and Experimental Immunology, 2007